Compare SUPN & CHRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUPN | CHRN |
|---|---|---|
| Founded | 2005 | 2026 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2014 | 2012 |
| Metric | SUPN | CHRN |
|---|---|---|
| Price | $29.57 | $10.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $54.14 | $28.50 |
| AVG Volume (30 Days) | ★ 2.4M | 143.0K |
| Earning Date | 10-29-2026 | 11-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | 92.67 |
| EPS | ★ 2.78 | N/A |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | $51.56 | $84.77 |
| Revenue Next Year | $30.35 | $603.10 |
| P/E Ratio | $10.65 | ★ N/A |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $25.92 | $10.00 |
| 52 Week High | $59.68 | $30.00 |
| Indicator | SUPN | CHRN |
|---|---|---|
| Relative Strength Index (RSI) | 31.65 | 34.16 |
| Support Level | $25.92 | $10.00 |
| Resistance Level | $51.59 | $22.29 |
| Average True Range (ATR) | 2.00 | 1.59 |
| MACD | -0.52 | -0.19 |
| Stochastic Oscillator | 19.96 | 7.24 |
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.
ChronoScale Holdings Corp is providing cloud services to customers at third-party colocation centers located in Colorado, Minnesota and Utah, such as artificial intelligence and machine learning developers, seeking to develop their products. It design, develop, and market exoskeleton and complementary products that augment human strength, endurance, and mobility. Its Cloud Business provides graphics processing unit (GPU) computing solutions that enable customers to execute critical workloads related to artificial intelligence (AI), machine learning (ML), rendering, and other High Performance Computing (HPC) tasks at scale in a capacity-constrained market. It has one operating segment Cloud Business.